本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

39.54
-1.4100-3.44%
盘后39.00-0.5400-1.37%19:41 EDT
成交量:456.17万
成交额:1.78亿
市值:36.47亿
市盈率:-138.08
高:40.00
开:39.83
低:38.12
收:40.95
52周最高:43.31
52周最低:13.88
股本:9,224.16万
流通股本:9,122.00万
量比:0.86
换手率:5.00%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:31.76
市盈率(LYR):-138.08

数据加载中...

2022/08/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/17

重要事件披露

8-K/A [Amend] - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/12

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/20

重要事件披露

8-K - Current report
2022/03/21

重要事件披露

8-K - Current report
2022/03/11

重要事件披露

8-K - Current report
2022/03/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/03/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals